BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Healthtrust
Citi
Cipla
Moodys
Novartis
Baxter
Chinese Patent Office
Argus Health
UBS

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,954,703

« Back to Dashboard

Which drugs does patent 5,954,703 protect, and when does it expire?

Patent 5,954,703 protects LEVULAN and is included in one NDA.

This patent has fifteen patent family members in sixteen countries.
Summary for Patent: 5,954,703
Title: Method and apparatus for applying 5-aminolevulinic acid
Abstract:A method and apparatus for storing, mixing and applying ALA as a treatment for lesions. The apparatus comprises a deformable container enclosing a hermetically sealed compartment of essentially anhydrous ALA which is shielded from exposure to air and moisture, and a liquid diluent. The liquid diluent may be in a second compartment. The deformable container is squeezed to crush the compartments and mix the essentially anhydrous ALA with the liquid diluent. The ALA may be delivered from the deformable container through a point applicator for controlling and precisely directing the application during treatment.
Inventor(s): Golub; Allyn (Miramar, FL)
Assignee: Dusa Pharmaceuticals, Inc. (Ontario, CA)
Application Number:08/962,294
Patent Claim Types:
see list of patent claims
Use; Delivery; Device; Formulation;

Drugs Protected by US Patent 5,954,703

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Dusa LEVULAN aminolevulinic acid hydrochloride SOLUTION;TOPICAL 020965-001 Dec 3, 1999 RX Yes Yes ➤ Subscribe ➤ Subscribe TREATMENT OF NON-HYPERKERATOTIC ACTINIC KERATOSES OF FACE AND SCALP ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,954,703

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 272422 ➤ Subscribe
Australia 1278399 ➤ Subscribe
Australia 738070 ➤ Subscribe
Brazil 9813887 ➤ Subscribe
Germany 69825464 ➤ Subscribe
Denmark 1027093 ➤ Subscribe
European Patent Office 1027093 ➤ Subscribe
Spain 2226188 ➤ Subscribe
Hungary 0004737 ➤ Subscribe
Israel 135850 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Farmers Insurance
Fish and Richardson
Novartis
Dow
Queensland Health
Julphar
Argus Health
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot